169 related articles for article (PubMed ID: 29270101)
21. Characterization of Total and Unprotonated (Free) Nicotine Content of Nicotine Pouch Products.
Stanfill S; Tran H; Tyx R; Fernandez C; Zhu W; Marynak K; King B; Valentín-Blasini L; Blount BC; Watson C
Nicotine Tob Res; 2021 Aug; 23(9):1590-1596. PubMed ID: 34233354
[TBL] [Abstract][Full Text] [Related]
22. A content analysis of Camel Snus advertisements in print media.
Timberlake DS; Pechmann C; Tran SY; Au V
Nicotine Tob Res; 2011 Jun; 13(6):431-9. PubMed ID: 21385907
[TBL] [Abstract][Full Text] [Related]
23. Patterns of Use of Smokeless Tobacco in US Adults, 2013-2014.
Cheng YC; Rostron BL; Day HR; Stanton CA; Hull LC; Persoskie A; Travers MJ; Taylor K; Conway KP; Ambrose BK; Borek N
Am J Public Health; 2017 Sep; 107(9):1508-1514. PubMed ID: 28727534
[TBL] [Abstract][Full Text] [Related]
24. Characterising advertising strategies and expenditures for conventional and newer smokeless tobacco products.
Emery SL; Binns S; Carter CC; Rose SW; Kostygina G
Tob Control; 2023 Nov; 32(6):795-798. PubMed ID: 35803674
[TBL] [Abstract][Full Text] [Related]
25. Tobacco Product Use and Associated Factors Among Middle and High School Students -
United States, 2019.
Wang TW; Gentzke AS; Creamer MR; Cullen KA; Holder-Hayes E; Sawdey MD; Anic GM; Portnoy DB; Hu S; Homa DM; Jamal A; Neff LJ
MMWR Surveill Summ; 2019 Nov; 68(12):1-22. PubMed ID: 31805035
[TBL] [Abstract][Full Text] [Related]
26. In vitro study of nicotine release from smokeless tobacco.
Nasr MM; Reepmeyer JC; Tang Y
J AOAC Int; 1998; 81(3):540-3. PubMed ID: 9606918
[TBL] [Abstract][Full Text] [Related]
27. Determination of nicotine absorption from multiple tobacco products and nicotine gum.
Digard H; Proctor C; Kulasekaran A; Malmqvist U; Richter A
Nicotine Tob Res; 2013 Jan; 15(1):255-61. PubMed ID: 22585541
[TBL] [Abstract][Full Text] [Related]
28. Use of internal documents to investigate a tobacco company's strategies to market snus in the United States.
Rhee JU; Abugazia JY; Cruz YMED; Timberlake DS
Tob Prev Cessat; 2021; 7():11. PubMed ID: 33598590
[TBL] [Abstract][Full Text] [Related]
29. Smokeless tobacco: a gateway to smoking or a way away from smoking.
Melikian AA; Hoffmann D
Biomarkers; 2009 Jul; 14 Suppl 1():85-9. PubMed ID: 19604066
[TBL] [Abstract][Full Text] [Related]
30. Do Emotions Spark Interest in Alternative Tobacco Products?
Popova L; So J; Sangalang A; Neilands TB; Ling PM
Health Educ Behav; 2017 Aug; 44(4):598-612. PubMed ID: 28071144
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of moist snuff in humans.
Fant RV; Henningfield JE; Nelson RA; Pickworth WB
Tob Control; 1999; 8(4):387-92. PubMed ID: 10629244
[TBL] [Abstract][Full Text] [Related]
32. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus).
Alizadehgharib S; Lehrkinder A; Alshabeeb A; Östberg AK; Lingström P
Eur J Oral Sci; 2022 Aug; 130(4):e12885. PubMed ID: 35853092
[TBL] [Abstract][Full Text] [Related]
33. Test marketing of new smokeless tobacco products in four U.S. cities.
Rogers JD; Biener L; Clark PI
Nicotine Tob Res; 2010 Jan; 12(1):69-72. PubMed ID: 19917598
[TBL] [Abstract][Full Text] [Related]
34. Associations of Proposed Relative-Risk Warning Labels for Snus With Perceptions and Behavioral Intentions Among Tobacco Users and Nonusers.
Rodu B; Plurphanswat N; Hughes JR; Fagerström K
Nicotine Tob Res; 2016 May; 18(5):809-16. PubMed ID: 26253616
[TBL] [Abstract][Full Text] [Related]
35. The composition of contemporary American and Swedish smokeless tobacco products.
McAdam KG; Kimpton H; Faizi A; Porter A; Rodu B
BMC Chem; 2019 Dec; 13(1):31. PubMed ID: 31384779
[TBL] [Abstract][Full Text] [Related]
36. A novel model mouth system for evaluation of In Vitro release of nicotine from moist snuff.
Li P; Zhang J; Sun SH; Xie JP; Zong YL
Chem Cent J; 2013 Nov; 7(1):176. PubMed ID: 24215662
[TBL] [Abstract][Full Text] [Related]
37. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
[TBL] [Abstract][Full Text] [Related]
38. Smokers' Exposure to Perceived Modified Risk Claims for E-Cigarettes, Snus, and Smokeless Tobacco in the United States.
Wackowski OA; O'Connor RJ; Pearson JL
Nicotine Tob Res; 2021 Feb; 23(3):605-608. PubMed ID: 32812028
[TBL] [Abstract][Full Text] [Related]
39. Smokeless tobacco products sold in Massachusetts from 2003 to 2012: trends and variations in brand availability, nicotine contents and design features.
Cullen D; Keithly L; Kane K; Land T; Paskowsky M; Chen L; Hayes R; Li W
Tob Control; 2015 May; 24(3):256-62. PubMed ID: 24420311
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
